CITY OF HOPE launched an institute focused on treating blood and bone marrow diseases: the Hematologic Malignancies and Stem Cell Transplantation Institute.
The institute will be composed of six centers, individually focused on research in lymphoma, myeloma, leukemia, T cell immunotherapy, stem cell transplantation, and gene therapy. These include the Toni Stephenson Lymphoma Center and the Gehr Family Center for Leukemia Research.
The institute has recruited several prominent researchers, including Larry Kwak, chairman of the Department of Lymphoma/Myeloma at MD Anderson Cancer Center and associate director of its Center for Cancer Immunology Research; Jasmine Zain, associate director for the Bone Marrow Transplantation Program at the College of Physicians and Surgeons at the New York Presbyterian Hospital and Herbert Irving Comprehensive Cancer Center at Columbia University; John Chan, co-director of the Center for Leukemia and Lymphoma Research and co-leader of the Lymphoma Research Program at the University of Nebraska; Guido Marcucci, professor of internal medicine and molecular virology, immunology and medical genetics, and pharmaceutics in the Division of Hematology at Ohio State University Comprehensive Cancer Center; and Christiane Querfeld, dermatopathologist and lymphoma specialist at Memorial Sloan-Kettering Cancer Center.
The institute is currently launching several T cell immunotherapy clinical trials for treatment of leukemia and lymphoma, with others being developed for myeloma and transplantation.
